CVS Health Corp (NYSE: CVS) has reported earnings for its third fiscal quarter (ending September 30) of $0.07 versus $1.76 for the same period a year ago — a decline of -96%. E.P.S. were $3.95 for the latest four quarters through September 30 versus $6.68 for the same period a year ago — a decline of -41%.
Recent Price Action
CVS Health Corp (NYSE: CVS) stock enjoyed a major increase of 11.3% on 11/6/24. The shares closed at $61.61. Moreover, exceptionally high trading volume at 255% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 9.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, CVS is expected to continue to be a major Value Builder.
CVS Health has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CVS Health has a very high Appreciation Score of 93 but a very low Power Rating of 14, leading to the Neutral Value Trend Rating.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment